Head-to-head comparisons of medication uses, side effects, warnings, and more.
Susvimo (ranibizumab) is an eye implant for adults with wet age-related macular degeneration (AMD). It's also approved for adults with diabetic macular edema (DME) or diabetic retinopathy (DR). This medication works as a vascular endothelial growth factor (VEGF) inhibitor. You can only get this eye implant if you've already done well with at least two eye injections of a VEGF inhibitor. Once placed in the eye, the implant releases medication over several months before it needs to get refilled at an eye specialist's office. This helps you need fewer eye injections. But side effects can include blood spots on the eye and eye pain.
Lucentis (ranibizumab) is a medication used to prevent vision loss and blindness due to certain eye conditions such as macular degeneration or diabetic macular edema. It's given by a healthcare provider as an injection into your eye about once a month. There are two FDA-approved biosimilar medications to Lucentis (ranibizumab) called Byooviz and Cimerli.
Conditions related to swelling or damage to the macula or retina (parts of the eye that are important for vision):
Lucentis and all its biosimilars
Lucentis and Cimerli biosimilar only
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.